The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

Blood

Volumn 109, Issue 1, 2007, Pages 145-154

  James, Paula D ^a   Notley, Colleen ^a   Hegadorn, Carol ^a   Leggo, Jayne ^a   Tuttle, Angie ^a   Tinlin, Shawn ^a   Brown, Christine ^a   Andrews, Chandler ^a   Labelle, Andrea ^a   Chirinian, Yvette ^a   O'Brien, Lee ^a   Othman, Maha ^a   Rivard, Georges ^b   Rapson, Dilys ^a   Hough, Christine ^a   Lillicrap, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; CANADA; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VON WILLEBRAND DISEASE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; PHENOTYPE; POINT MUTATION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33846026307     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-021105.     Document Type: Article

References (33)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454-459.
2. Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993;123:893-898.
3. Ruggeri ZM. The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces. Thromb Haemost. 1995;74:460-463.
4. Lynch DC, Zimmerman TS, Collins CJ, et al. Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell. 1985;41:49-56.
5. Sadler JE, Shelton-Inloes BB, Sorace JM, et al. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci U S A. 1985;82:6394-6398.
6. Ginsburg D, Handin RI, Bonthron DT, et al. Human von Willebrand factor (vWF): isolation of complementary DNA(cDNA) clones and chromosomal localization. Science. 1985;228:1401-1403.
7. Verweij CL, Diergaarde PJ, Hart M, Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J. 1986;5:1839-1847.
8. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem. 1989;264:19514-19527.
9. Titani K, Kumar S, Takio K, et al. Amino acid sequence of human von Willebrand factor. Biochem. 1986;25:3171-3184.
10. Mohlke KL, Nichols WC, Westrick RJ, et al. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. Proc Natl Acad Sci U SA. 1996;93:15352-15357.
11. Mohlke KL, Purkayastha AA, Westrick RJ, et al. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell. 1999;96:111-120.
12. Bodo I, Katsumi A, Tuley EA, et al. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Blood. 2001;98:2973-2979.
13. Castaman G, Eikenboom JC, Missiaglia E, Rodeghiero F. Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect. Br J Haematol. 2000;108:876-879.
14. Eikenboom JC, Matsushita T, Reitsma PH, et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood. 1996;88:2433-2441.
15. O'Brien LA, James PD, Othman M, et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003;102:549-557.
16. NCCLS. Collection, Transport and Preparation of Blood Specimens for Coagulation Testing and Performance of Coagulation Assays. Bethesda, MD: National Committee for Clinical Laboratory (NCCLS) Standards Institute; 2005: no. 23. Document H21-A2.
17. Hardisty RM, MacPherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh. 1962;7:215-228.
18. Budde U, Schneppenheim R, Plendl H, et al. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost. 1990;63:312-315.
19. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19:5444.
20. Yip SP. Sequence variation at the human ABO locus. Ann Hum Genet. 2002;66:1-27.
21. Olsson ML, Chester MA. Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies. Transfus Med. 2001;11:295-313.
22. James PD, Paterson AD, Notley CR, et al. Genetic linkage and association analysis in type 1 von Willebrand disease (VWD): results from the Canadian Type 1 VWD Study. J Thromb Haemost. 2006;4:783-792.
23. Bowen DJ, Collins PW. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood. 2004;103:941-947.
24. University of Sheffield. ISTH SSC VWF Database. http://www.VWF.group. shef.ac.uk/index.html. Accessed November 1, 2006.
25. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002;12:436-446.
26. Ramensky V, Bork P, Sunyaev S. Human nonsynonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894-3900.
27. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus "variants." Blood. 1980;56:712-716.
28. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69:1691-1695.
29. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol. 2001;67:125-129.
30. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease, I: phenotypic variation within families. Blood. 1979;54:117-136.
31. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood. 2003;101:2089-2093.
32. Tjernberg P, Van Der Heijden JF, Eikenboom JC, Reitsma PH. Evaluation of the von Willebrand factor Y1584C polymorphism as a potential risk factor for bleeding in patients receiving anticoagulant treatment with vitamin K antagonists. J Thromb Haemost. 2005;3:797-798.
33. Hilbert L, Jorieux S, Proulle V, et al. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol. 2003;120:627-632.